Pseudomonas aeruginosa reduces the expression of CFTR via post-translational modification of NHERF1

Rosa Rubino(University of Bari Aldo Moro), Anna Tamanini(University of Verona), Stephan J. Reshkin(University of Bari Aldo Moro), Valentino Bezzerri(Azienda Ospedaliera Universitaria Integrata Verona), Ursula Seidler(Medizinische Hochschule Hannover), Brigitte Riederer(Medizinische Hochschule Hannover), Anurag Kumar Singh(National Institute of Technology Tiruchirappalli), Alessandra Bragonzi(Vita-Salute San Raffaele University), Marcella Facchini(The San Raffaele Telethon Institute for Gene Therapy), Antonio Iannucci(University of Verona), Giulio Cabrini(University of Verona), Maria Favia(University of Bari Aldo Moro), Maela Tebon(University of Verona)
Pflügers Archiv - European Journal of Physiology
March 4, 2014
10.1007/s00424-014-1474-6
Cited by 25

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409